Cargando…
Enhancing the Delivery of Resveratrol in Humans: If Low Bioavailability is the Problem, What is the Solution?
Resveratrol has emerged as a leading candidate for improving healthspan through potentially slowing the aging process and preventing chronic diseases. The poor bioavailability of resveratrol in humans has been a major concern for translating basic science findings into clinical utility. Although a n...
Autores principales: | Smoliga, James M., Blanchard, Otis |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6270951/ https://www.ncbi.nlm.nih.gov/pubmed/25347459 http://dx.doi.org/10.3390/molecules191117154 |
Ejemplares similares
-
Development of a Lozenge for Oral Transmucosal Delivery of Trans-Resveratrol in Humans: Proof of Concept
por: Blanchard, Otis L., et al.
Publicado: (2014) -
Enhancing Bioavailability of Nutraceutically Used Resveratrol and Other Stilbenoids
por: Vesely, Ondrej, et al.
Publicado: (2021) -
A Brief Updated Review of Advances to Enhance Resveratrol’s Bioavailability
por: de Vries, Konrad, et al.
Publicado: (2021) -
Galactosylated PLGA nanoparticles for the oral delivery of resveratrol: enhanced bioavailability and in vitro anti-inflammatory activity
por: Siu, Frederick YK, et al.
Publicado: (2018) -
Strategies to Improve Resveratrol Systemic and Topical Bioavailability: An Update
por: Intagliata, Sebastiano, et al.
Publicado: (2019)